June 25, 2020 / 6:38 AM / 13 days ago

BRIEF-Medivir: European Commission Grants Orphan Medicinal Product Designation In EU For MIV-818

June 25 (Reuters) - Medivir AB:

* THE EUROPEAN COMMISSION HAS GRANTED ORPHAN MEDICINAL PRODUCT DESIGNATION IN THE EU FOR MIV-818

* EMA GRANTED ORPHAN MEDICINAL PRODUCT DESIGNATION IN EU FOR MIV-818 FOR TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA

* DESIGNATION CAN GIVE ACCESS TO SEVERAL INCENTIVES, INCLUDING PROTOCOL ASSISTANCE, EU CENTRALIZED AUTHORIZATION PROCEDURE AND REDUCED REGULATORY FEES AND A POTENTIAL FOR A 10-YEAR MARKET EXCLUSIVITY IN EU Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below